SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051308
Filing Date
2020-11-05
Accepted
2020-11-05 16:09:38
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2020 10-Q srpt-10q_20200930.htm   iXBRL 10-Q 4286249
2 EX-10.1 srpt-ex101_14.htm EX-10.1 101454
3 EX-31.1 srpt-ex311_10.htm EX-31.1 10539
4 EX-31.2 srpt-ex312_6.htm EX-31.2 11134
5 EX-32.1 srpt-ex321_8.htm EX-32.1 7188
6 EX-32.2 srpt-ex322_9.htm EX-32.2 7651
  Complete submission text file 0001564590-20-051308.txt   11492633

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200930.xsd EX-101.SCH 60907
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20200930_cal.xml EX-101.CAL 75108
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20200930_def.xml EX-101.DEF 157029
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200930_lab.xml EX-101.LAB 412597
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200930_pre.xml EX-101.PRE 305802
12 EXTRACTED XBRL INSTANCE DOCUMENT srpt-10q_20200930_htm.xml XML 2126141
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 201290504
SIC: 2834 Pharmaceutical Preparations